POLYPEPTIDE N/ CH1110760852 /
2024-09-05 5:30:13 PM | Chg. -0.250 | Volume | Bid5:40:00 PM | Ask5:40:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
32.000CHF | -0.78% | 6,932 Turnover: 221,465.150 |
31.500Bid Size: 350 | 32.500Ask Size: 100 | 1.06 bill.CHF | - | - |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | -1.56 EUR | -750.00% |
EPS Diluted: | - EUR | - |
Revenues per Share: | 9.81 EUR | 14.60% |
Book Value per Share: | 11.56 EUR | -9.20% |
Cash Flow per Share: | 1.10 EUR | 129.11% |
Dividend per Share: | - EUR | - |
Total | in mill. | |
Revenues: | 324.85 EUR | 14.60% |
Net Income: | -51.44 EUR | -762.29% |
Operating Cash Flow: | 36.49 EUR | - |
Cash and Cash Equivalents: | 95.71 EUR | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | - | - |
P/S Ratio: | 3.48 | 1.91 |
P/BV ratio: | 2.95 | 1.62 |
P/CF Ratio: | 30.94 | 17.03 |
PEG: | 0.03 | - |
Earnings Yield: | -4.58% | -8.32% |
Dividend Yield: | - | - |
Market Capitalization | ||
Market Capitalization: | 1.06 bill. CHF | 575.35 mill. CHF |
Free Float Market Cap.: | - CHF | - CHF |
Market Cap. / Employee: | 881,863.5873 CHF | 478,658.5242 CHF |
Shares Outstanding: | 33.13 mill. |
Profitability
Gross Profit Margin: | 2.81% |
EBIT Margin: | -11.23% |
Net Profit Margin: | -15.83% |
Return on Equity: | -13.44% |
Return on Assets: | -7.46% |
Financial Strength
Liquidity I / Cash Ratio: | 54.24% |
Liquidity II / Quick Ratio: | 97.69% |
Liquidity III / Current Ratio: | 185.10% |
Debt / Equity Ratio: | 79.98% |
Dynam. Debt / Equity Ratio: | 839.29% |
Efficiency
Employees: | 1,202 |
Personal Expenses / Employee: | - EUR |
Revenues / Employee: | 270,260.40 EUR |
Net Income / Employee: | -42,795.34 EUR |
Total Assets / Employee: | 573,284.53 EUR |
* Fiscal Year End: | 2023-12-31 |
Accounting Standard: | IFRS |
Currency: | EUR |